GPBAR1 and depressive symptom measurement: In general, inhibition of FXR and activation of TGR5 in the hippocampus induces BDNF levels and mitigates depression-like symptoms in mice (Huang et al., 2015; Chen et al., 2018b; Hu et al., 2020).